CPHI Milan Speaker Spotlight: CDMO relations with Pharma and Start-Ups
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences.
We spoke with Bernardo Estupiñán Gaisbauer, Managing Partner at CDMO Advisor, to discuss how CDMO relations are evolving in the pharmaceutical industry, including those with start-ups.
Catch Gaisbauer as he speaks at the sessions ‘Navigating Shifts in CDMO-Pharma Relations: Trends and Implications’ (Tuesday October 8, 2024, 11:35am-12:30pm) and ‘Fireside Chat – Navigating Outsourcing Partnerships for Start-Ups' (Tuesday October 8, 2024, 1:15pm-1:40pm).
1. For start-ups, what are some important aspects to consider when looking for a CDMO partnership?
Very important for startups is to define short-, medium-, and long-term objectives. I say this because often startups are focused on long-term objectives and want to partner with a CDMO with commercial experience. While this is nice it is not a realistic objective. Short- and medium-term objectives should be the focus, and looking for CDMOs with expertise in development and troubleshooting is critical. It is important to get the proof-of-concept (POC) along with developability and manufacturability studies firmed up so that the program can make it into the clinic. One-stop shops are OK, but the boutique niche service providers may deliver greater value for the cost.
2. For CDMOs, what makes for a worthwhile partnership with a start-up?
This really depends on the CDMO. We track CDMOs that go from ‘Boutique’ to ‘one-stop shops’ and the reality is that all CDMOs want to partner with a start-up, particularly if they are well funded. This, however, may not be a worthwhile partnership. A worthwhile partnership hinges on fair give and take. Helping the start-up reach the clinic through a combination of goodwill and revenue has been something I have always tried to achieve when I was working on the CDMO side, and it is something that I look for now that I work on the start-up side. This makes it a worthwhile partnership because a start-up helps the CDMO grow its expertise and long-term, as more projects are added to the start-up pipeline, these projects ultimately feed the CDMO’s own sales funnel. In return, the CDMO helps the start-up achieve its milestones, clinical objectives, and financial goals. This is a true win-win partnership.
3. How do events like CPHI help foster partnerships between CDMOs and start-ups?
Events like CPHI provide a forum where CDMOs can meet with start-ups and vice versa. Meeting is how you start a partnership, and this allows you to very quickly determine if a partnership is even possible. It is always important to mix business with social interactions, and events like CPHI provide both the business forum and the social and networking forum.
4. What are you most looking forward to at this year’s CPHI?
I am really looking forward to the business and networking forum during CPHI. For one, I am incredibly thankful and appreciative for Informa to have asked me to chair a session, host a panel, and to participate in a fire-chat. I came wearing many hats representing not only my own company, CDMO Advisor, but also the startups I am with, including CellViva and Project Insulin, and the service providers I consult for, such as Vectron Biosolutions, Olon, and Pyramid Labs. CPHI is the place to do all this business and networking, so a lot to really look forward to!
CPHI Milan takes place October 8-10 at the historic Fiera Milano and there's still time to register! Click here to find out more.
Related News
-
News Eisai Alzheimer’s drug authorised in UK but still faces obstacles
In partnership with BioArctic AB, pharmaceutical company Eisai has been granted Marketing Authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) for its Alzheimer’s disease drug product Leqembi. -
News Women in Pharma: A leader's approach to diversity advocacy
In our monthly series on women in the pharmaceutical industry, we interview leading experts in the pharmaceutical supply and value chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva. -
News US FDA does not approve MDMA therapy for PTSD, requests more data
The MDMA-based therapeutic developed by Lykos Therapeutics, a California-based Public Benefit Corporation (PBC), has been reviewed and unapproved by the US FDA. The regulator has requested additional phase III trial data for further safety and efficacy... -
News Novartis and Viatris latest facing lawsuit over HeLa cell misuse
Global pharmaceutical companies Novartis and Viatris are the latest hit with a lawsuit claim pertaining to alleged misuse of the ‘HeLa’ cell line from the estate of woman whose cancerous tissue cells were taken without consent. -
News Sanofi invests billions into Frankfurt insulin production site
French pharmaceutical company Sanofi have announced an investment of EUR1.3 billion at their existing BioCampus site in Frankfurt am Main for the expansion of insulin production. -
News Novel oral Type 1 diabetes drug gains US FDA IND designation
A University of Alabama at Birmingham startup has gained FDA clearance for Investigational New Drug clinical trials for an oral Type 1 diabetes drug, a milestone for diabetes treatment. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance